[1] Franks PW, Hanson RL, Knowler WC, et al.Childhood obesity, other cardiovascular risk factors, and premature death[J].N Engl J Med, 2010, 362(6):485-493. [2] Babinska K, Kovacs L, Janko V, et al.Association between obesity and the severity of ambulatory hypertension in children and adolescents[J].J Am Soc Hypertens, 2012,6:356-363. [3] Ohashi K, Shibata R, Murohara T, et al.Role of anti-inflammatory adipokines in obesity-related diseases[J].Trends Endocrinol Metab, 2014, 25(7):348-355. [4] Shah R, Gayat E, Januzzi JL, et al.Body mass index and mortality in acutely decompensated heart failure across the world:a global obesity paradox[J].J Am Coll Cardiol, 2014, 63(8):778-785. [5] Niu J, Seo DC.Central obesity and hypertension in Chinese adults:a 12-year longitudinal examination[J].Prev Med, 2014,62:113-118 [6] Rahmouni K.Obesity-associated hypertension:recent progress in deciphering the pathogenesis[J].Hypertension, 2014, 64(2):215-221. [7] Vaněcˇková I, Maletínská L, Behuliak M, et al.Obesity-related hypertension:possible pathophysiological mechanisms[J].J Endocrinol, 2014, 223(3):R63-R78. [8] Holm JC,Gamborg M, Neland M, et al.Longitudinal changes in blood pressure during weight loss and regain of weight in obese boys and girls[J].J Hypertens, 2012, 30:368-374. [9] Landgraf K, Friebe D, Ullrich T, et al.Chemerin as a mediator between obesity and vascular inflammation in children[J].J Clin Endocrinol Metab, 2012,97(4):E556-E564. [10] Sharma M, McClung JA, Abraham NG.Adiponectin:a mediator of obesity, insulin resistance, diabetes, and the metabolic syndrome[M]//Translational Research in Coronary Artery Disease,2016:33-42.
|